Healthcare Realty Trust Incorporated (HR) Q4 2025 Earnings Call Transcript
Normalized FFO per share $1.61, exceeding the midpoint of original guidance by $0.03. This was driven by strong leasing activity, improved property-level and G&A expense controls, and higher same-store occupancy.
Same-store NOI growth 4.8%, exceeding the midpoint of original guidance by 140 basis points. This was attributed to improved leasing spreads, tenant retention, and occupancy gains.
Cash leasing spreads Improved by 60 basis points year-over-year due to a revamped leasing model and better alignment between asset management and leasing.
Tenant retention Improved by 220 basis points year-over-year, reflecting better leasing strategies and tenant satisfaction.
Property NOI margins Improved by 60 basis points year-over-year, with expectations for further margin expansion in the future.
Asset dispositions $1.2 billion of assets sold at a blended 6.7% cap rate, exceeding expectations. This included exiting 14 noncore markets and improving the geographic footprint into high-growth MSAs.
Net debt to EBITDA Reduced nearly a full turn to 5.4x, providing financial flexibility and improving the company's credit outlook to stable from Moody's and S&P.
Dividend yield Nearly 6%, following a rightsizing of the dividend to ensure it is well-covered and sustainable.
Leasing activity 5.8 million square feet executed in 2025, with annual escalators averaging 3.1%, lifting the portfolio average to 2.9%.
Same-store occupancy Improved by over 100 basis points year-over-year, driven by strong leasing activity and tenant retention.
Redevelopment lease percentage Increased by 1,000 basis points since the end of Q3 2025, driven by strong demand in redevelopment projects.
Q4 2025 normalized FFO per share $0.40, driven by 103 basis points of year-over-year same-store occupancy gains, 3.7% cash leasing spreads, and continued expense controls.
Q4 2025 same-store cash NOI growth 5.5%, reflecting strong leasing spreads and occupancy gains.
Full-year FAD per share $1.26, resulting in a quarterly dividend payout ratio of 75%.
Debt repayment $900 million repaid in 2025, including $700 million in Q4, reducing leverage and extending debt maturities by 12 to 24 months.
Trade with 70% Backtested Accuracy
Analyst Views on HR
About HR
About the author

- Tesla Rating Upgrade: JR Research has upgraded Tesla (TSLA) to Buy, believing the market is reassessing its potential as a physical AI company, particularly the long-term value from robotaxis and full self-driving technology, even though the stock remains far below its historical highs.
- Healthcare Realty Trust Confidence: Albert Anthony upgraded Healthcare Realty Trust (HR) to Buy, emphasizing favorable macro trends such as an aging population and rising outpatient demand, predicting that this REIT will outperform the S&P 500, despite limited short-term upside for the stock price.
- CoreWeave Downgrade: Oliver Rodzianko downgraded CoreWeave (CRWV) from Strong Buy to Sell, noting that despite significant revenue growth, high capital intensity and insufficient profitability make the current valuation stretched, raising concerns about future cash flow sustainability.
- AMD Rating Adjustment: Juxtaposed Ideas downgraded Advanced Micro Devices (AMD) from Buy to Hold, indicating that while the company benefits significantly from AI, overbought technicals and rapid price increases pose risks of profit-taking at inflated levels.
- Portfolio Value: Starboard Value reported a first-quarter portfolio value of $4.57 billion, with Qorvo accounting for 13% of total holdings, indicating strong confidence in Qorvo and potential implications for future investment strategies.
- Client and Asset Management: As of March 6, 2026, Starboard managed approximately $8.15 billion in assets with 11 clients, reflecting its solid position and appeal in the hedge fund industry.
- Major Holdings Analysis: The fund held 7.51 million shares of Qorvo worth about $581 million, followed by Kenvue with 27.31 million shares valued at approximately $470.78 million, showcasing a diversified investment strategy in technology and consumer goods sectors.
- Quant Ratings Overview: Among Starboard's top 15 holdings, Kenvue and Acacia Research received quant ratings of 4.37 and 4.60 respectively, indicating their market potential and attractiveness to investors, which may influence investment decisions.
- Increased Offering Size: Healthcare Realty Trust's operating partnership raised the offering of exchangeable senior notes from $500 million to $600 million, reflecting heightened market confidence and providing stronger financial support for future capital operations.
- Interest Rate and Maturity: The notes carry an interest rate of 3.00% and are set to mature on January 15, 2032, ensuring predictable financial planning for the company with stable interest payments over the term.
- Clear Use of Proceeds: The company expects net proceeds of approximately $582.6 million, with plans to allocate about $75 million for repurchasing approximately 3.83 million shares, while the remaining funds will be used to repay its 3.500% senior notes due in 2026, emphasizing a focus on optimizing capital structure.
- Attractive Conversion Terms: The notes can be exchanged for about 43.47 shares per $1,000, with a conversion price of around $23.01 per share, representing a 17.5% premium over the last close of $19.58 on May 4, 2026, which may attract investor interest and enhance shareholder value.
- Financing Plan: Healthcare Realty Trust (NYSE:HR) announced its operating partnership plans to offer $500 million of exchangeable senior notes due 2032 in a private placement, indicating the company's proactive approach to capital market utilization.
- Additional Option: The company may grant initial purchasers an option to buy up to an additional $75 million of notes, providing flexibility to adjust the financing scale based on market demand, thereby enhancing its capital structure.
- Use of Proceeds: Proceeds from this offering will be used in part to repurchase shares, fund capped call transactions, and repay debt, including its 3.50% senior notes due 2026, aimed at optimizing financial health and enhancing shareholder value.
- Market Condition Dependency: The offering is subject to market conditions, with final terms to be determined at pricing, reflecting the company's cautious stance in an uncertain market environment.
- Bond Offering Size: Healthcare Realty Trust (HR) announced a $500 million offering of exchangeable senior notes due in 2032, aimed at enhancing the company's capital structure and financial flexibility through this strategic move.
- Additional Purchase Option: Initial purchasers have the option to buy an additional $75 million in notes within 13 days of issuance, providing investors with further participation opportunities that could enhance market demand for these notes.
- Diverse Use of Proceeds: Proceeds from the bond offering will fund capped call transactions, repay existing debt, and support potential share repurchases, demonstrating the company's proactive strategy in optimizing its capital structure and enhancing shareholder value.
- Capital Preservation and Compliance: The company may also use the funds for general capital preservation investments and to maintain REIT tax compliance, ensuring financial stability and regulatory adherence in its future operations.
- Leasing Performance Breakthrough: Healthcare Realty Trust signed over 2 million square feet of leases in Q1, marking an all-time high that reflects strong market demand and growth potential, which is expected to drive future revenue growth further.
- Same-Store NOI Growth: Same-store NOI grew nearly 7%, with occupancy improving to 92.3%, indicating significant progress in asset utilization and profitability, thereby enhancing investor confidence in long-term growth prospects.
- Stock Buyback Program: The company has repurchased $100 million of stock, with $400 million remaining under its buyback authorization, demonstrating management's confidence in future performance while providing returns to shareholders, which is expected to boost earnings per share.
- Upgraded Financial Outlook: The company raised its full-year normalized FFO per share guidance by $0.01 to a range of $1.59 to $1.65, reflecting management's optimistic outlook for future performance, although it does not include additional acquisitions or incremental buybacks, showcasing a cautious capital allocation strategy.








